Progressive Multiple Sclerosis Clinical Trials in London, Greater London
2 recruitingLondon, Greater London, United Kingdom
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)
Progressive Multiple Sclerosis
Hoffmann-La Roche360 enrolled47 locationsNCT07282574
Recruiting
Phase 1
SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis
Relapsing Remitting Multiple SclerosisPrimary Progressive Multiple SclerosisSecondary Progressive Multiple Sclerosis
Queen Mary University of London72 enrolled1 locationNCT03783416